Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

Company Overview - Co-Diagnostics Inc is a molecular diagnostics company specializing in the development, manufacturing, and marketing of advanced diagnostics technologies [5] - The company utilizes proprietary technology to design tests for its Co-Dx PCR platform, targeting at-home and point-of-care use, as well as genetic marker identification for non-infectious disease applications [5] International Expansion - Co-Diagnostics is participating in a World Trade Center Utah trade mission to South Korea and Japan from September 24 to October 5, 2024, as part of its global expansion strategy [1] - The company aims to strengthen international relationships, particularly in the life sciences and innovation sectors, through this trade mission [2] - Co-Diagnostics has established a joint venture in India (CoSara Diagnostics Pvt Ltd) in 2017 and built a network of distributors, partners, and customers in over 50 countries [2] Product Development - The company is preparing to introduce a new PCR diagnostic platform designed for at-home and point-of-care use [2] - Co-Diagnostics' technology focuses on the detection and analysis of nucleic acid molecules (DNA or RNA) for diagnostic tests [5] Strategic Partnerships - Co-Diagnostics is collaborating with Utah Governor Cox and the Governor's Office of Economic Opportunity for the trade mission [1] - The company has distributed millions of COVID-19 PCR tests globally during the pandemic years, establishing a strong international presence [2] Leadership Vision - CEO Dwight Egan emphasizes the importance of building a global network to improve access to high-quality PCR diagnostics worldwide [4] - The company's mission aligns with advancing patient care accessibility and increasing the availability of diagnostic solutions [4]